WD-890 for moderate to severe plaque psoriasis
Part of Skin clinical trials.
This study tests an investigational drug called WD-890 for people with moderate-to-severe plaque psoriasis that hasn't responded well enough to other treatments. It may help reduce skin patches, scaling, and itching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have plaque psoriasis for at least 6 months
- Psoriasis covers at least 10% of your body (like 10 palm-sized patches)
- Your psoriasis is moderate to severe (a score of 12 or higher on a severity scale called PASI)
- You are between 18 and 70 years old
- You do not have poorly controlled high blood pressure (above 160/100) or severe heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pill called WD-890 to see if it can help people with moderate to severe plaque psoriasis. The pill is compared to a placebo (a pill with no medicine) to check if it is safe and works well.
This trial tests an experimental drug called ICP-488 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve symptoms and is safe, and may be an option if you need stronger treatment than creams or light therapy.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
Hear when a new Brief Description of Focus of Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.